Summary
Parathyroid hormone-related protein (PTHRP) has recently been purified from human tumors associated with the syndrome of humoral hypercalcemia of malignancy. The gene encoding PTHRP has been cloned, and based on predicted amino acid sequence, polypeptides comprising the first 36 [36Tyr(1–36) PTHRP amide] and 74 [(1–74)PTHRP] amino acids have been synthesized. Human (h) PTHRP (1–36) and (1–74) are potent bone-resorbing agents, and are catabolic for bone in vivo when given continuously at high doses. Bovine parathyroid hormone (bPTH) (1–34) is also catabolic for bone at high dose levels, but when given in low doses for weeks to months, it is anabolic. Although PTHRP possess several PTH-like properties in bone, hPTHRP (1–34) is reported to be only weakly anabolic in vivo. As polypeptide length influences PTHRP action, we evaluated hPTHRP(1–74) as an anabolic agent for bone in vivo. Twenty-four 4-week-old male Sprague-Dawley rats were given daily subcutaneous injections of hPTHRP(1–74) (1 and 2 nmol/100 g body weight, bw), bPTH(1–34) (4 nmol/100 g bw) or vehicle. Rats were sacrificed on day 12, and serum calcium, phosphorus, and 1,25 dihydroxyvitamin D and femoral bone dry weight, calcium content, and hydroxyproline content were measured. Serum calcium and phosphorus were equivalent in all groups. A significant increase in dry bone weight was observed in both PTHRP-treated groups compared with controls. PTHRP also caused a significant, dose-dependent increase in bone calcium and hydroxypro-line content. Results of these studies indicate that PTHRP (1–74) is anabolic for bone in vivo when administered at low-dosage levels for a prolonged period.
Similar content being viewed by others
References
Burtis W, Wu T, Bunch C, Wysolmerski J, Insogna K, Broadus AE, Weir EC, Stewart AF (1987) Identification of a novel 17,000 dalton PTH-like adenylate-cyclase stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem 262:7151–7156
Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall REH, Kemp BE, Suva LJ, Rodda CP, Ebeling PR, Hudson PJ, Zajac JD, Martin TJ (1987) Parathyroid hormone-related protein purified from a human lung carcinoma cell line. Proc Natl Acad Sci USA 84:5048–5052
Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M, Nessenson RA (1987) Parathyroid hormone-like protein from human renal carcinoma cells. J Clin Invest 80:1803–1807
Mangin M, Webb AC, Dreyer BE, Posillico JT, Ikeda K, Weir EC, Stewart AF, Bander NH, Barton DE, Francke U, Broadus AE (1988) Identification of a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. Proc Natl Acad Sci 85:597–601
Suva LJ, Winslow GA, Wettenhall REH, Hammonds RG, Mosely JM, Difenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY, Hudson PJ, Martin TJ, Wood WI (1987) A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237:893–896
Stewart AF, Mangin M, Wu T, Goumas D, Insongna KL, Burtis WJ, Broadus AE (1988) Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats. J Clin Invest 81:596–600
Stewart AF, Elliot J, Burtis WJ, Wu T, Insogna KL (1989) Synthetic parathyroid hormone-like protein (1–74): biochemical and physiological characterization. Endocrinology 22:642–648
Collib JB, Clark EP (1925) Further studies on the physiological action of a parathyroid hormone. J Biol Chem 64:485–507
Raisz LG (1976) Mechanisms of bone resorption. In: Aurbach GD (ed) Handbook of physiology, vol III. Washington, DC, Am Physiol Soc 117–136
Johnston CC Jr, Deiss WP, Miner EB (1962) Bone matrix biosynthesis in vitro II. Effects of parathyroid hormone. J Biol Chem 237:3560–3565
Gunness-Hey M, Hock JM (1984) Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis Rel Res 5:177–181
Hori M, Uzawa T, Morita K, Noda T, Takahashi H, Inoue J (1988) Effect of human parathyroid hormone (PTH)(1–34) on experimental osteopenia of rats induced by ovariectomy. Bone Miner 3:193–199
Hefti E, Trechsel U, Bonjour JP, Fleisch H, Scheak R (1982) Increase of whole-body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone. Clin Sci 62:389–396
Podbesek R, Edouard C, Meunier PJ (1983) Effects of two treatment regimens with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology 112:1000–1006
Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OLM, Courpron P, Edouard C, Klenerman L, Neer RM, Renier JC, Slovik D, Visman FJ, Potts JT Jr (1980) Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J 280:1340–1344
Hock JM, Fanesca J, Gunners-Hey M, Kemp BE, Martin TJ (1989) Comparison of the anabolic effects of synthetic parathyroid human-related protein (PTHRP) 1–34 and PTH 1–34 on bone in rats. Endocrinology 125:2022–2027
Kitazawa R, Imai Y, Fukase M, Fujita T (1991) Effects of continuous infusion of parathyroid hormone and parathyroid hormone-related peptide on rat bone in vivo: comparative study by histomorphometry. Bone Miner 12:157–166
Thorikay M, Kramer S, Reynolds FH, Sorvillo JM, Doescher L, Wu T, Morris CA, Burtis WJ, Insogna KL, Valenzuela DM, Stewart AF (1989) Synthesis of a gene encoding parathyroid hormone-like protein (1–141): purification and biological characterization of the expressed protein. Endocrinology 124:111–118
Yaegaki K, Tonzetich J, Ng ASK (1986) Improved high-performance liquid chromatography method for quantitation of proline and hydroxyproline in biological materials. J Chromatography 356:163–170
Zettner A, Seligson D (1964) Application of atomic absorption spectrophotometry in the determination of calcium in serum. Clin Chem 10:869–890
Fiske C, Subbarow T (1925) The colormetric determination of phosphorus. J Biol Chem 66:375
Insogna KL, Mitnick ME, Stewart AF, Burtis WJ, Mallette LE, Broadus AE (1985) Sensitivity of the parathyroid hormone 1,25-dihydroxyvitamin D axis to variations in calcium intake in patients with primary hyperparathyrodism. N Engl J Med 313:1126–1130
Burrows R (1938) Variations produced in bones of growing rats by parathyroid extracts. Am J Anat 62:237–290
Parsons JA, Reit B (1974) Chronic response of dogs to parathyroid hormone infusion. Nature 250:254
Tam CS, Hersche JNM, Murray TM, Parsons JA (1982) Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology 110:506–511
Kalu D, Pennock J, Doyle FH, Foster GV (1970) Parathyroid hormone and experimental osteosclerosis. Lancet 1:1363–1366
Wronski TJ, Lowry PL, Walsh CC, Ignaszewski LA (1985) Skeletal alterations in ovariectomized rats. Calcif Tissue Int 37:324–328
Slovik DM, Neer RM, Potts JT (1981) Short-term effects of synthetic human parathyroid hormone (1–34) administration on bone mineral metabolism in osteoporotic patients. J Clin Invest 68:1201–1271
Slovik DM, Rosenthal DI, Doppelt SH, Potts JT Jr, Daly MA, Campbell JA, Neer RM (1986) Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25-dihydroxyvitamin D. J Bone Miner Res 1:377–381
Canalis E, McCarthy TL, Centrella M (1990) Differential effects of continuous and transient treatment with parathyroid hormone-related peptide (PTHrp) on bone collagen synthesis. Endocrinology 126:1806–1812
Liu CC, Kalu DN (1990) Human parathyroid hormone (1–34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats. J Bone Miner Res 5:973–982
Hock JM, Hummert J, Boyce R, Fonseca J, Raisz LG (1989) Resorption is not essential for the stimulation of bone growth by human parathyroid hormone 1–34 in rats in vivo. J Bone Miner Res 4:449–458
Raisz LG, Kream BE (1981) Hormonal control of skeletal growth. Annu Rev Physiol 43:225–238
McGuire JL, Marks SC (1974) The effects of parathyroid hormone on bone cell structure and function. Clin Orthop Rel Res 100:392–405
Murrills RJ, Stein LS, Fey CP, Dempster DW (1990) The effects of parathyroid hormone (PTH) and PTH-related peptide on osteoclast resorption of bone slices in vitro: an analysis of pit size and the resorption focus. Endocrinology 127:2648–2653
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weir, E.C., Terwilliger, G., Sartori, L. et al. Synthetic parathyroid hormone-like protein (1–74) is anabolic for bone in vivo . Calcif Tissue Int 51, 30–34 (1992). https://doi.org/10.1007/BF00296214
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00296214